Terms ending in 2032
Every in-force patent on Intervet Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,050,281 | Coccidiosis Vaccines In force · High confidence | Intervet, Inc. and Intervet International B.V. | In force | High confidence | |
| US 9,066,864 | Use of Liquid Medium Exchange by Cross Flow Filtration in the Preparation of Drug Suspensions In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,139,618 | Salmonid Alphavirus Protein E2 In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,359,602 | Immunostimulatory Oligodeoxynucleotides In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,364,531 | Immunostimulatory Oligodeoxynucleotides In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,006,272 | Pharmaceutical Compositions and Method for Treating Inflammation in Cattle and Other Animals In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 8,932,604 | Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Newcastle Disease Virus Antigens In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 9,409,954 | Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Newcastle Disease Virus Antigens In force · High confidence | Intervet Inc. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.